BDP® 558/568 carboxylic acid
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
17490 | 1 mg | $125 | in stock | |
27490 | 5 mg | $260 | in stock | |
47490 | 25 mg | $510 | in stock | |
57490 | 50 mg | $895 | in stock | |
67490 | 100 mg | $1490 | in stock |
BDP 558/568 is a universal borondipyrromethene dye with emission in the yellow region of the spectrum. This derivative is a free carboxylic acid.
Absorption and emission spectra of BDP 558/568
Customers also purchased with this product
BDP® R6G carboxylic acid
Free carboxylic acid derivative of BDP R6G - a borondipyrromethene dye with absorption and emission spectra resembling R6G rhodamine.
Add this product to your cart and
get free express delivery
get free express delivery
AF 647 carboxylic acid
AF 647 carboxylic acid is a water-soluble dye that can be used as a reference standard for dye conjugates and the synthesis of AF647-containing biomolecules.BDP® TMR carboxylic acid
Borondipyrromethene dye for TMR channel with a non-activated carboxylic acid group.General properties
Appearance: | dark colored solid |
Molecular weight: | 346.16 |
CAS number: | 150173-72-1 |
Molecular formula: | C16H13N2BF2O2S |
Solubility: | good in DCM, DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 561 |
ε, L⋅mol−1⋅cm−1: | 84400 |
Emission maximum, nm: | 569 |
Fluorescence quantum yield: | 0.68 |
CF260: | 0.00 |
CF280: | 0.07 |
Product citations
- Kochappan, R.; Cao, E.; Han, S.; Hu, L.; Quach, T.; Senyschyn, D.; Ferreira, V.I.; Lee, G.; Leong, N.; Sharma, G.; Lim, S.F.; Nowell, C.J.; Chen, Z.; von Andrian, U.H.; Bonner, D.; Mintern, J.D.; Simpson, J.S.; Trevaskis, N.L.; Porter, C.J.H. Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice. Journal of Controlled Release, 2021, 332, 636–651. doi: 10.1016/j.jconrel.2021.02.008
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.